Clariane SELTS:0OPS -3.09%61 EV-to-FCF is 10.71 as of Jun. 30, 2026, which is 63% below its 10-year median of 29.28. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 407 Healthcare Providers & Services companies, Clariane SE ranks better than 66.83% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Clariane SE's Enterprise Value is €8,737 Mil.
Clariane SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €816 Mil. Therefore, Clariane SE's EV-to-FCF for today is 10.71.
The historical rank and industry rank for Clariane SE's EV-to-FCF or its related term are showing as below:
LTS:0OPS'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.4 Med: 29.28 Max: 57.23
Current: 10.77
During the past 13 years, the highest EV-to-FCF of Clariane SE was 57.23. The lowest was 10.40. And the median was 29.28.
LTS:0OPS's EV-to-FCF is ranked better than 66.83% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 17.51
vs LTS:0OPS: 10.77
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Clariane SE's PE Ratio (TTM) for today is calculated as:
Clariane SE's share price for today is €4.104.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.004.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Clariane SE EV-to-FCF Related Terms
Clariane SE EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Clariane SE's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Clariane SE's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Clariane SE's EV-to-FCF falls into.
Clariane SE's current Enterprise Value is €8,737 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €816 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (LTS:0OPS) has a EV-to-FCF of 10.71 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Clariane SE and its competitors. This is 63% below median its historical median of 29.28. Over the past decade, Clariane SE's EV-to-FCF has ranged from 10.40 to 57.23. According to the industry distribution chart, Clariane SE ranks #135 out of 407 companies in the Healthcare Providers & Services industry, placing it in the top 33.2%.
Is Clariane SE's EV-to-FCF too high?
Clariane SE's current EV-to-FCF of 10.71 is 63% below median its 10-year median of 29.28. Over the past 10 years, this metric has ranged from a low of 10.40 to a high of 57.23. The Healthcare Providers & Services industry median EV-to-FCF is 17.51. Clariane SE's value of 10.71 is 38.8% below this industry median. Based on the distribution chart, Clariane SE ranks #135 out of 407 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #135 out of 407 companies for EV-to-FCF. This puts Clariane SE in the upper half of its industry. The industry median EV-to-FCF is 17.51. Clariane SE's value of 10.71 is 38.8% below this benchmark. Historically, Clariane SE's own EV-to-FCF has ranged from 10.40 to 57.23 over the past decade. While the company's 10-year median is 29.28 vs. the industry median of 17.51, Clariane SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.51, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current EV-to-FCF of 10.71 is 38.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current EV-to-FCF is 10.71, which is 63% below median its own 10-year median of 29.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.10 — trading 64.8% above its estimated fair value. The current EV-to-FCF is 10.71, which is 63% below median its 10-year median of 29.28 and 38.8% below the Healthcare Providers & Services industry median of 17.51. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current EV-to-FCF is 10.71 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (LTS:0OPS) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.10 is trading 64.8% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for LTS:0OPS:
EV-to-FCF: 10.71 (63% below median its 10-year median of 29.28)
GF Value™: €2.49 vs. price of €4.10 (64.8% above fair value)
Industry Position: 38.8% below the Healthcare Providers & Services median (#135 of 407)
No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for LTS:0OPS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OPS has been successfully added to your 
